The Food and Drug Administration Friday issued final guidance clarifying that an organization may operate both a compounding pharmacy and outsourcing facility at the same address or general location if they are completely segregated by clearly identified boundaries, for example permanent physical barriers such as walls or doors that are locked. If the pharmacy is not completely segregated from the outsourcing facility, FDA would generally consider the pharmacy part of the outsourcing facility and subject to Section 503B of the Federal Food, Drug and Cosmetic Act and current good manufacturing practice, the agency said. Both compounders also should clearly label their drug products as compounded at a pharmacy or outpatient facility, FDA said. The Drug Quality and Security Act of 2013 created the outsourcing facility category.

Related News Articles

Headline
Sens. Lamar Alexander, R-Tenn., and Patty Murray, D-Wash., today introduced the Lower Health Care Costs Act (S.1895), legislation to prevent surprise medical…
Headline
The House of Representatives last night passed legislation (H.R. 3253) that includes an AHA-supported provision that would extend the Community Mental Health…
Headline
Aligning for Health voiced support for legislation to improve the collection of data related to the social determinants of health for Medicare and Medicaid…
Headline
The Senate Committee on Health, Education, Labor and Pensions today held a hearing on the Lower Health Care Costs Act, its draft legislation to prevent…
Headline
AHA said it generally supports the reforms to update the payment system, but expressed concern with the substantial redistribution of cases under the payment…
Headline
The departments of Labor, Health and Human Services, and the Treasury yesterday finalized a rule that will allow employers to use health reimbursement…